(CTHR) Charles Colvard - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1597651066
CTHR: Moissanite, Jewels, Jewelry, Diamonds, Gemstones
Charles & Colvard Ltd (NASDAQ:CTHR) is a fine jewelry company specializing in lab-created gemstones, primarily moissanite and lab-grown diamonds. Operating through two segments, Online Channels and Traditional, the company markets its products under the Charles & Colvard Created Moissanite and Forever One brands for moissanite, and the Caydia brand for lab-grown diamonds. Their product range includes loose gemstones and finished jewelry, sold through various channels such as their websites, third-party marketplaces, and a physical showroom. Incorporated in 1995, the company is headquartered in Morrisville, North Carolina, and has established a presence in the sustainable jewelry market, appealing to eco-conscious consumers.
The companys focus on lab-created gemstones positions it in a growing niche, emphasizing sustainability and ethical sourcing. Their distribution strategy includes both wholesale to retailers and direct-to-consumer sales, leveraging a strong e-commerce presence. Recent developments in consumer preference towards lab-grown diamonds and moissanite have placed Charles & Colvard in a potential growth sector, despite current financial challenges.
3-Month Forecast:
Technical Data Insights: - The stocks low average volume of 8,905 shares indicates a micro-cap stock with limited liquidity, suggesting higher volatility. - The last price of $1.09 is below the 20-day SMA of $1.27, indicating a bearish trend. - The 50-day SMA at $1.41 and 200-day SMA at $1.60 further confirm the downward trend. - The ATR of 0.10 signals low volatility, with price movements expected to remain within a narrow range.
Fundamental Data Insights: - The market cap of $3.53M reflects a small, high-risk investment. - A P/E ratio of 0 indicates current unprofitability, while a forward P/E of 112.36 suggests investor expectations of significant earnings growth. - The low P/B ratio of 0.11 and P/S of 0.15 suggest undervaluation relative to book value and revenue. - The negative RoE of -59.15% highlights substantial losses, necessitating a turnaround for sustained growth.
Forecast Outlook: - Price Movement: Expected to remain volatile, potentially testing lower support levels due to bearish SMA trends. - Triggers: Upcoming earnings reports and revenue growth announcements are critical for stock movement. - Sentiment: Investor sentiment may shift based on the companys ability to meet growth expectations and improve profitability. - Risk/Reward: While undervaluation metrics offer potential, the high forward P/E and profitability concerns pose significant risks.
Additional Sources for CTHR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CTHR Stock Overview
| Market Cap in USD | 3m |
| Sector | Consumer Cyclical |
| Industry | Luxury Goods |
| GiC Sub-Industry | Apparel, Accessories & Luxury Goods |
| IPO / Inception | 1997-11-14 |
CTHR Stock Ratings
| Growth 5y | -82.7% |
| Fundamental | -45.6% |
| Dividend | 2.50% |
| Rel. Strength | -73.5 |
| Analysts | - |
| Fair Price Momentum | 0.59 USD |
| Fair Price DCF | - |
CTHR Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 10.0% |
CTHR Growth Ratios
| Growth Correlation 3m | -92.6% |
| Growth Correlation 12m | -88% |
| Growth Correlation 5y | -67.5% |
| CAGR 5y | -32.93% |
| CAGR/Max DD 5y | -0.34 |
| Sharpe Ratio 12m | -1.94 |
| Alpha | -68.44 |
| Beta | 1.277 |
| Volatility | 58.36% |
| Current Volume | 30.9k |
| Average Volume 20d | 6.6k |
As of April 05, 2025, the stock is trading at USD 0.92 with a total of 30,914 shares traded.
Over the past week, the price has changed by -8.00%, over one month by -14.81%, over three months by -38.26% and over the past year by -72.53%.
Probably not. Based on ValueRay Fundamental Analyses, Charles Colvard (NASDAQ:CTHR) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -45.56 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CTHR as of April 2025 is 0.59. This means that CTHR is currently overvalued and has a potential downside of -35.87%.
Charles Colvard has no consensus analysts rating.
According to ValueRays Forecast Model, CTHR Charles Colvard will be worth about 0.6 in April 2026. The stock is currently trading at 0.92. This means that the stock has a potential downside of -30.43%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 1.1 | 19.6% |
| Analysts Target Price | 1.1 | 19.6% |
| ValueRay Target Price | 0.6 | -30.4% |